cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Intra Cellular Therapies Inc
13 own
15 watching
Current Price
$59.38
$-0.05
(-0.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
5,681.48M
52-Week High
52-Week High
66.56
52-Week Low
52-Week Low
42.01
Average Volume
Average Volume
0.49M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization5,681.48M
icon52-Week High66.56
icon52-Week Low42.01
iconAverage Volume0.49M
iconDividend Yield--
iconP/E Ratio--
What does the Intra Cellular Therapies Inc do?
Intra-Cellular Therapies, Inc., a biopharmaceutical company, engages in developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases and diseases of the elderly, including Parkinson's and Alzheimer's disease. The company is developing its lead drug candidate, lumateperone, known as ITI-007, for the treatment of schizophrenia, bipolar disorder, behavioral disturbances in patients with dementia, depression, and other neuropsychiatric and neurological disorders. Lumateperone, a molecule, is in Phase III clinical development for the treatment of schizophrenia, bipolar depression, and agitation associated with dementia, including Alzheimer's disease. The company is also utilizing its phosphodiesterase platform and other proprietary chemistry platforms to develop drugs for the treatment of central nervous system and other disorders. Intra-Cellular Therapies, Inc. is headquartered in New York, New York.
Read More
How much money does Intra Cellular Therapies Inc make?
News & Events about Intra Cellular Therapies Inc.
PR Newswire
3 months ago
Thinking about trading options or stock in Sarepta Therapeutics, Tesla, Intra-Cellular Therapies, NVIDIA, or First Solar? Thinking about trading options or stock in Sarepta Therapeutics, Tesla, Intra-Cellular Therapies, NVIDIA, or First Solar? PR Newswire NEW YORK, March 1, 2023 NEW YORK, March 1...
Globe Newswire
3 months ago
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc.(Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced it will host a conference call and live webcast ...
Globe Newswire
3 months ago
NEW YORK, Feb. 08, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and ...
Globe Newswire
4 months ago
NEW YORK, Jan. 03, 2023 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sharon Mates, Ph.D., Chief Executive Officer and ...
Globe Newswire
5 months ago
NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced four data presentations at the American College of ...
Frequently Asked Questions
Frequently Asked Questions
What is Intra Cellular Therapies Inc share price today?
plus_minus_icon
Can Indians buy Intra Cellular Therapies Inc shares?
plus_minus_icon
How can I buy Intra Cellular Therapies Inc shares from India?
plus_minus_icon
Can Fractional shares of Intra Cellular Therapies Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Intra Cellular Therapies Inc stocks?
plus_minus_icon
What is today’s traded volume of Intra Cellular Therapies Inc?
plus_minus_icon
What is today’s market capitalisation of Intra Cellular Therapies Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Intra Cellular Therapies Inc?
plus_minus_icon
What percentage is Intra Cellular Therapies Inc down from its 52-Week High?
plus_minus_icon
What percentage is Intra Cellular Therapies Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$59.38
$-0.05
(-0.08%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
$22.07
$0.27 (1.24 %)
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc.
$5.97
$0.05 (0.84 %)
Ascendis Pharma A/S
Ascendis Pharma A/S
$86.97
$1.19 (1.39 %)
Omeros Corporation
Omeros Corporation
$6.20
$0.35 (5.98 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
Collegium Pharmaceutical Inc
Collegium Pharmaceutical Inc
$22.07
$0.27 (1.24 %)
Minerva Neurosciences, Inc.
Minerva Neurosciences, Inc.
$5.97
$0.05 (0.84 %)
Ascendis Pharma A/S
Ascendis Pharma A/S
$86.97
$1.19 (1.39 %)
Omeros Corporation
Omeros Corporation
$6.20
$0.35 (5.98 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00